Drug response screening of leukemia stem cells offers clues to relapse and suggests ways to improve patient-specific therapies.
Your genes could help lead to better care for a patient in the future.
It was a big day for UW Medicine, Fred Hutchinson Cancer Research Center, and other local medical science leaders at GeekWire Summit 2018, a Seattle present-meets-future technology conference.
Upfront tumor DNA sequencing might simultaneously provide both better detection sensitivity than standard tests, and critical information for treatment.
Dr. Tony Blau founded All4Cure, an online knowledge-sharing website for doctors, researchers and patients with multiple myeloma, a cancer of the plasma cells.
Greg Ledwon, a patient with acute myeloid leukemia says he is slaying cancer and is excited about the prospects of curing leukemia.
UW Medicine genome scientist Jay Shendure describes precision medicine -- that is, the idea that cell-based research might revolutionize medical care, yielding therapies personalized to individual patients.
UW Medicine, Fred Hutchinson Cancer Research Center, and Seattle Children's will collaborate to discover personalized treatments based on patients' genetic and molecular profiles.
Goal is to develop personalized therapies for tens of millions of people with the two most common kidney diseases.
Investigators gave enrollees a frank assessment of potential benefits, but human spirit seemed to overpower that message